Dr. Naveen Atray
Dr. Naveen Atray
1111 Exposition Blvd., Suite 300
Sacramento, CA 85815
Ph: 916-564-6232
Fax: 916-564-6242
Send an Email to: Dr. Atray

Medical School


MBBS, King George Medical College, Lucknow, India.


Internship and Residency:


Residency, Orthopedics, King George Medical College & Gandhi Memorial Hospital

Residency, Internal Medicine, St. Barnabas Hospital/Cornell University, New York


Interventional Nephrology Training


AngioJet Rheolytic Thrombectomy System for AV Access Applications. From Possis Medical Inc.


Nephrology Fellowship


Clinical Fellowship, Nephrology & Hypertension, Louisiana State University Health Sciences Center, Shreveport, LA

Clinical Fellowship, Interventional Nephrology, Louisiana State University Health Sciences Center, Shreveport, LA . Competent in and routinely doing the following procedures:
  • Tunneled Catheters/Subcutaneous Vascular Ports
  • Thrombectomy and Angioplasty of AV Grafts/ Native Fistula / Transposed
  • Stents Deployments / Coil Embolization
  • Peritoneal Catheters Placement

Mini-fellowship in Renal Ultrasonography, Emory University Hospital, Atlanta, GA


Specialty Boards:


Diplomate in Internal Medicine, American Board of Internal Medicine

Diplomate in Nephrology, American Board of Internal Medicine

Specialist in Hypertension, American Society of Hypertension

Diplomate, American Board of Hospital Physicians

Diplomate, American College of Ethical Physicians

Fellow of American Society of Nephrology (FASN)


Licensure


California A93005

Louisiana 13599R

Educational Commission for Foreign Medical Graduates (ECFMG): 0-545-980-5

Federal DEA License

Medical Council of India


Work Experience


Medical Director, Capital Nephrology Access Center

Medical Director, DaVita Sunrise Dialysis Unit, Rancho Cordova, CA

Staff Priveleges at all DaVita Dialysis Sites

Sutter Hospital, Sacramento, CA

Mercy Health Care System, Sacramento, CA

Staff Physician, Overton Brooks VA Medical Center, Shreveport, LA

Staff Physician, LSU Health Sciences Center, Shreveport, LA

Staff Physician, Willis Knighton Medical Center, LA

Staff Physician, Dialysis Center of Shreveport, Shreveport, LA

Staff Physician, Dialysis Clinic Inc., Shreveport, LA


Professional Societies


American Society of Diagnostic and Interventional Nephrology

American Society of Hypertension

American Society of Nephrology

American Federation of Medical Research

Member, Private Nephrologists Advisory Group, American Society of Nephrology

Member, Kidney Council - American Heart Association

Chair, Communications Committee, American Society of Diagnostic and Interventional Nephrology

Member, Scientific Council, Southern Chapter of American Federation Medical Research (AFMR)

Hospital Peer Review Committee

Hospital Pharmacy & Therapeutics Committee

Chair, Abstract Session, Second Annual Scientific Meeting, American Society of Diagnostice and Interventional Society, San Antonio, TX

Invited Faculty, Post-Graduate Workshop, National Kidney Foundation Spring Meeting, Chicago

Faculty Speaker, Third Annual Scientific Meeting, American Society of Diagnostic and Interventional Nephrology, Puerto Rico

Editor, American Society of Diagnostic Nephrology website (www.asdin.org)


Teaching Experience


Medical Students: History & Physical, bedside teaching, Sophomore lectures and small group sessions

Medical Residents: Didactic lecture and bedside teaching, procedures

Nephrology Fellows: Didactic lectures, Journal clubs, Interventional procedures, clinical teaching


Research


A Phase III, Randomized Double-Blind, Parallel Group, Placebo-Controlled, Multi-Center Trial Evaluating the Efficacy and Safety of XXX in Adult Patients on Chronic Hemodialysis.

A Phase III, Randomized, Active-Controlled, Open-label, Multi-Center Study of the Safety and Efficacy of XXX Injection for the Maintenance Treatment of Anemia in Hemodialysis Patients previously treated with Epogen.

A Phase IV, Long Term, Observational Safety Study in End Stage Renal Disease Subjects Treated with XXX.

A Phase II, Randomized, Double-Blind, Placebo-Controlled, Mult-Center, to Evaluate the Safety and Efficacy of XXX in Patients with Nephropathy Due to Type 2 Diabetes.

Patient Focus Group for Qualitative Assessment of Anemia Associated with Chronic Kidney Disease.

A Multi-Center, Randomized, Double-Blinded Study to Evaluate Efficacy and Safety of XXX in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease who are on Dialysis and who have Inadequate Glycemic Control.

A Phase II Study of the Safety and Efficacy of XXX injection for the Maintenance Treatment of Anemia in Subjects with Chronic Renal Failure who are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.


Publications


Longitudinal Study of Hemodialysis Graft Stenosis: Role of Progressive

Honors and Awards



Selected Clinical Trials:



Certificate of Completion